CareDx

CAREDX INC

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Cathie Wood Smelling AI Opportunity? Ark Invest Buys Tempus AI Dip, Scoops Up Over $13 M Worth Of Stock

Equities

News

Markets

ETFs

ARKF

ARKG

ARKK

ARKW

CDNA

GTLB

IBTA

NTLA

PATH

PRME

RBLX

RPTX

Ark Invest&#39;s Cathie Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Roblox, Repare Therapeutics, and CareDx.

Cathie Wood&#39;s Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta

Fintech news covering the emerging Financial Technology services sector

Fintech

Tech

EVER

EZPW

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

New Strong Buy Stocks For February 27th

movers image

Pre-Market Outlook

Movers

Trading Ideas

ACEL

CART

FLYW

LBTYK

LMND

NAMS

SGRY

ZETA

Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday&#39;s Pre-Market Session

CareDx Inc

CANADIAN TIRE LTD A by Canadian Tire Corp. Ltd.

Canadian Tire Corp Ltd

Press Releases

CareDx to Report Fourth Quarter and Full Year 2024 Financial Results

CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies

Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders

CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict

CareDx Announces Fourth Quarter and Full Year 2024 Financial Results

CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

CareDx Launches Two Expanded Indications for AlloSure Testing Services

CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

Legal

SHAREHOLDER ALERT: Kaskela Law LLC Announces Class Action Lawsuit Against CareDx, Inc (CDNA) and Encourages Long-Term CareDx Investors to Contact the Firm

Ardelyx

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Dyne Therapeutics

89bio

Geron

GRAIL

Gyre Therapeutics

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics

MiMedx Group

Mineralys Therapeutics, Inc. - Common Stock

Mineralys Therapeutics

Myriad Genetics

Nurix Therapeutics

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics

Novavax

Rocket Pharmaceuticals, Inc. - Common Stock

Rocket Pharmaceuticals

Arcus Biosciences

Syndax Pharmaceuticals, Inc. - Common Stock

Syndax Pharmaceuticals

ARS Pharmaceuticals

Spyre Therapeutics

Vir Biotechnology

Viridian Therapeutics, Inc. - Common Stock

Viridian Therapeutics

Xencor

Zymeworks

HC Wainwright & Co.

Stephens & Co.

Wells Fargo

BTIG

Goldman Sachs

Comments

CareDx

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga